Latest filing published 22 Apr 2026 for Pharma Mar, S.A., €9,345. Read the official filing
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of José María Fernández Sousa-Faro in Pharma Mar, S.A. Over a trading history stretching from 24 January 2022 to 21 April 2026, the count stands at 12 filings.
Every open-market trade on record is a purchase: 12 purchases worth €315k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €8,044. Relative to company size, the median is 0.0004% of market cap (11 purchases with a known value). On 11 out of 12 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 8 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 38% of cases, with a median move of -9.2%. This is a record of the past, not a forecast.
The newest entry dates from 22 April 2026: an open-market purchase of €9,345, in Pharma Mar, S.A. Typically, a trade is published a median of 1 day after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by CNMV. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations